Evaluation of the contraceptive efficacy of Quingestanol acetate in daily microdose and post coitum.
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced; D002584:Cervix Uteri / Q000473:pathology; D003276:Contraceptives, Oral / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D003281:Contraceptives, Postcoital / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D004717:Endometrium / Q000187:drug effects; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects; D008598:Menstruation / Q000187:drug effects; D009649:Norpregnadienes / Q000008:administration & dosage / Q000627:therapeutic use; D011247:Pregnancy; D011372:Progestins / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D003276:Contraceptives, Oral; D003281:Contraceptives, Postcoital; D009649:Norpregnadienes; D011372:Progestins